Michelle Bartkowski

Michelle Bartkowski serves as a Contracting Officer responsible for managing complex procurements within the federal acquisition system, focusing on specialized medical and diagnostic products and services. She plays a critical role in ensuring compliance with FAR regulations while advancing agency mission objectives through strategic sourcing. Her portfolio primarily encompasses the acquisition of in-vitro diagnostic substances, surgical appliances, medical instruments, and related healthcare support services. Bartkowski employs full and open competition as the default approach, while strategically leveraging small business set-asides to promote market diversity and innovation in high-technology medical sectors. While specific contractor names are not available, Bartkowski maintains consistent engagement with a broad base of manufacturers and suppliers specializing in medical device production and diagnostic laboratory solutions. Her contracting patterns reflect a preference for established industry players with proven regulatory compliance capabilities, particularly those holding ISO 13485 or FDA registration. She routinely collaborates with vendors capable of supporting stringent quality control, sterile manufacturing, and supply chain traceability requirements, fostering long-term partnerships grounded in performance accountability and regulatory alignment. Bartkowski demonstrates a strong commitment to small business participation, with approximately 15.8% of her awards designated as Total Small Business Set-Asides under FAR 19.5, and a modest but intentional allocation of 0.8% to 8(a) competed contracts. Her set-aside strategy prioritizes broad-based small business engagement over narrow socioeconomic categories, aligning with agency goals to expand vendor diversity while maintaining technical rigor. She avoids HUBZone and SDVOSB set-asides in her current portfolio, reflecting a targeted focus on manufacturing-capable small businesses rather than service-oriented socioeconomically disadvantaged firms. Her primary procurement focus centers on NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing), followed by surgical appliance and instrument manufacturing (339112 and 339113). She also regularly procures blood and organ banking services and specialized medical repair services under NAICS 811219. Bartkowski’s expertise lies in the technical domains of clinical diagnostics, sterile medical device production, and regulated healthcare supply chains, ensuring acquisitions meet rigorous federal standards for safety, efficacy, and reliability.